Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Psychopharmacology|August 15, 2009
Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patientsAna Alkelai, Lior Greenbaum, Amihai Rigbi, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
The International Journal of Neuropsychopharmacology|March 19, 2009
Further support for a role of the His452Tyr variant in 5-HT2A receptor gene in memory functions in humansAmihai Rigbi, Avraham Yakir, Kyra Kanyas, et al.
Journal of Clinical Psychology|April 12, 2008
Anorexia nervosa and parental bonding: the contribution of parent-grandparent relationships to eating disorder psychopathologyLaura Canetti, Kyra Kanyas, Bernard Lerer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2010
Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophreniaLior Greenbaum, Anna Alkelai, Amihai Rigbi, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
The International Journal of NeuropsychopharmacologyBernard Lerer, Alan Frazer, Stephen Stahl, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Psychiatric Genetics|December 18, 2009
No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish populationLior Greenbaum, Ilana Pelov, Omri Teltsh, et al.
The International Journal of Neuropsychopharmacology|September 17, 2003
T2-weighted image hyperintensities in major depression: focus on the basal gangliaRonit Agid, Tomer Levin, John Moshe Gomori, et al.
The Israel Journal of Psychiatry and Related Sciences|February 20, 2004
Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation statusAmihai Rigbi, Lilach Shalev-Mevorach, Aviva Taller, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Psychopharmacology|August 15, 2009
Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patientsAna Alkelai, Lior Greenbaum, Amihai Rigbi, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
The International Journal of Neuropsychopharmacology|March 19, 2009
Further support for a role of the His452Tyr variant in 5-HT2A receptor gene in memory functions in humansAmihai Rigbi, Avraham Yakir, Kyra Kanyas, et al.
Journal of Clinical Psychology|April 12, 2008
Anorexia nervosa and parental bonding: the contribution of parent-grandparent relationships to eating disorder psychopathologyLaura Canetti, Kyra Kanyas, Bernard Lerer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2010
Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophreniaLior Greenbaum, Anna Alkelai, Amihai Rigbi, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
The International Journal of NeuropsychopharmacologyBernard Lerer, Alan Frazer, Stephen Stahl, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Psychiatric Genetics|December 18, 2009
No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish populationLior Greenbaum, Ilana Pelov, Omri Teltsh, et al.
The International Journal of Neuropsychopharmacology|September 17, 2003
T2-weighted image hyperintensities in major depression: focus on the basal gangliaRonit Agid, Tomer Levin, John Moshe Gomori, et al.
The Israel Journal of Psychiatry and Related Sciences|February 20, 2004
Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation statusAmihai Rigbi, Lilach Shalev-Mevorach, Aviva Taller, et al.
Pageof 15